The stromal microenvironment in which tumor cells reside influences many steps of carcinogenesis and cancer progression. The influences of the microenvironment are mediated, in large part, by paracrine signaling between epithelial cells and neighboring stromal fibroblasts. In this proposal, we will contribute to the elucidation of the complex stromal/epithelial interactions involved in the initiation and development of breast cancer by utilizing relatively novel in vitro and in vivo models to assess the effect of human fibroblasts and their cellular products, emphasizing insulin like growth factor II (IGF-II), on the growth of non-transformed and partially transformed (""""""""pre-neoplastic"""""""") human breast epithelial cells. We will utilize the MCF10AT model of human proliferative breast disease, and the cell line from which the MCF10AT was originally derived, MCF10A cells. The hypothesis underlying this work is thus, there is a shift in insulin like growth factor (IGF) expression (from insulin like growth factor I (IGF-I) to IGF-II) in fibroblasts associated with carcinoma (FAC) and this shift is a key modulator of breast carcinogenesis. In support of this hypothesis, the proposed work will demonstrate the following: 1) When grown in three dimensional co-culture with non-transformed or partially transformed cells, FAC will result in an increase in the rate of cellular proliferation and a decreased rate of apoptosis of the co-cultured epithelial cells compared with epithelial cells grown with fibroblasts derived from benign breast (FAB). 2) The effect of increased proliferation and decreased apoptosis is, at least in part, a result of overexpression of IGF-II in FAC derived from breast carcinomas. 3) Overexpression of IGF-II in breast fibroblasts, when grown in vivo with MCF10AT cells will result in an increase in the number and degree of severity of proliferative lesions. An improved understanding of the role of fibroblasts and the IGF system in breast carcinogenesis is important to the development of effective preventive strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA097472-02
Application #
6608031
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (M1))
Program Officer
Perloff, Marjorie
Project Start
2002-07-15
Project End
2004-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
2
Fiscal Year
2003
Total Cost
$72,500
Indirect Cost
Name
University of Alabama Birmingham
Department
Pathology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Sadlonova, Andrea; Mukherjee, Shibani; Bowe, Damon B et al. (2007) Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease. Am J Pathol 170:1064-76
Hatsell, Sarah; Frost, Andra R (2007) Hedgehog signaling in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 12:163-73
Sadlonova, Andrea; Novak, Zdenek; Johnson, Martin R et al. (2005) Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Res 7:R46-59